Morning Headlines 10/23/15
NextGen’s hospital business is sold by its parent company Quality Systems to QuadraMed. Financial terms were not disclosed.
athenahealth, Inc. Reports Third Quarter Fiscal Year 2015 Results
Athenahealth reports Q3 results: revenue for the quarter was $236 million, up 24 percent, adjusted EPS $0.36 vs. $0.27, beating analyst projections on both.
New Research Finds Significant Number of Americans Not Getting Care at Right Hospitals
Healthgrades publishes a report concluding that patients treated in a 5-star rated hospital have “a 71 percent lower risk of dying or a 65 percent lower risk of experiencing complications” as compared to patients treated in a 1-star hospital.
Drug compounder offers cheap version of costly Turing drug
San Diego-based Imprimis Pharmaceuticals will begin selling a generic version of Daraprim for $1 per pill, down from its current price of $750 per pill, after national attention was drawn to the drug’s current manufacturer Turing Pharmaceuticals and its business model of buying the rights to rare but necessary medications with no generic equivalent and raising the price astronomically.
Sounds reasonable, until you look at the Silicon Valley experience. Silicon Valley grew like a weed precisely because employees could…